Jaguar8 commented on a stock · Oct 25, 2024 01:15

NEWS

Inozyme Pharma Announces Positive Interim Data from Phase 1 SEAPORT 1 Trial of INZ-701

Inozyme Pharma (INZY) announced positive interim data from its Phase 1 SEAPORT 1 trial of INZ-701 in patients with end-stage kidney disease (ESKD) undergoing hemodialysis. The trial demonstrated that INZ-701 significantly increased plasma pyrophosphate (PPi) levels in patients, with levels rising into the normal range by week 3 of the four-week dosing schedule. The drug was well-tolerated, with no drug-related treatment-emergent adverse events reported in the 11 patients who completed treatment. The company plans to initiate a registrational trial in calciphylaxis in 2025, pending regulatory alignment and funding.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

3253 Views

Comment

Jaguar8

Spread kindness and love. Life is short. Don’t let greed eat you.

8155

Followers

Following

93K

Visitors